George A. Digenis, Ph.D. - University of Kentucky - College of ...

National Institutes of Health, "Preparation and Disposition of 11 C- D- and L-Amino Acids,"
$51,137 (3rd year renewal).
Program for Applied Research Fertility Regulation, "Development of Methodology for
Following Microcapsule Transcervical Transport in Baboons Utilizing External Scintigraphy,"
$10,966.
Rowell Laboratories, "Cortenema Imaging Studies," $31,232 (lst year) Co- investigators: T.
Foster and M. Jay (1983).
INTERx, Merck, Sharp & Dohme Research Labs, "External Scintigraphy to Study Disposition
of Rectal Dosage Form Matrix In Vivo," $20,000 (2nd year). Co-investigator: M. Jay.
Ortho Pharmaceutical Corporation, "A Study on the Disposition of Vaginally Administered
Nonoxynol-9 in Barren and Pregnant Rats," $10,000 (1983).
"Ciba-Geigy Corporation, "External Scintigraphic Studies of Labeled Slow-K Tablets," $8,000
(1983).
"Polyamines and Suicide Inhibitors in Tumor Imaging," $178,000 (direct costs) National
Cancer Institute (1984-1987).
"Tobacco and Health Research Institute, "Design and Synthesis of Specific Human Leukocyte
Elastase Inhibitors", $55,139. (84-85).
"GI Transit Times of Two Radiolabelled Placebo Formulations", $7,000, (1984).
"Radionuclide Studies", $12,000, (G.A. Digenis and M.Jay), INTERx, Merck and Company
(1984).
"Neutron Activation Study", $15,000 (G.A. Digenis and M. Jay) $15,000, INTERx, Merck and
Company (84-85).
"Correlation of In Vitro and In Vivo Dissolution to Bioavailability by External Scintigraphy
and Perturbed Angular Correlation", $45,000, (84-86).
"Comparative Serum Concentratins of Theophylline in the Dog after Oral Administration of
111In-labelled Searle Theophylline CR-24 Preparation With and Without Food", $12,000,
Searle Research and Developement, Division of G.D. Searle and Company (1985).
"Radionuclide Studies" Interx, Merck and Company (continued), $20,025 (with Dr. M. Jay),
(85-86).
"Kinetics and Mechanism of Degradation of Aspartame", $25,000, Searle Research and
Development (Searle Food Resources) (with Dr. A. Hussain) (1986).
"Correlation of the GI Behavior of Erythromycin Beads to the Bioavailability of the Drugs",
pending, (b) "Disposition of Calcium Carbonate After Oral Administration in Man", Warner-
Lambert Co. $25,000 (1986)
"(a)"Synthesis of C-Alprazolam", pending; (b)"Synthesis and Preliminary Disposition studies
with 19 F-Flurbiprofen", The Upjohn Company, $110,000 (1986).
"Assessment of a Bioadhesive Coating on the GI Transit Time of Pellets in Humans", $75,000
(1986), "Purchase of Gamma Camera", $25,000, Eli Lilly, Company (1986).
"Novel Elastase Inhibitors: Mechanism and In Vivo Studies, $331,988 (3 years) National
Institute of Health, Pending (1986).
"Clinical Evaluation of Polymeric Dosage Forms of 5ASA", Eastman Kodak Company,
$70,000 (with Dr. T. Foster) December, 1986 - June, 1988.
"Studies on Polymerbound Peptidyl Carbamates", $43,500, Tobacco and Health Research
Institute, July, 1987 - June 1988.
47